Stay updated on CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial
Sign up to get notified when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.

Latest updates to the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page
- Check2 days agoChange DetectedUpdated the site page’s revision/version indicator from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedHepatocellular carcinoma keyword was added and a Genetic and Rare Diseases Information Center resource link was added under Resources. The page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page. This update does not affect study details or user-facing functionality.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2. The page content remains unchanged.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1, which is a minor software revision with no content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-122/Nivolumab Combo in Unresectable HCC Clinical Trial page.